FindTrial
Sign In

White blood cell parameters in COVID-19 infection

White blood cell parameters in patients diagnosed with COVID-19 - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055518
Enrollment
200
Registered
2023-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Not applicable: Not applicable Intervention2: Not applicable: Not applicable Control Intervention1: Not applicable: Not applicable

Sponsors

Rashmi Jain Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted to Lok Nayak Hospital who were diagnosed with COVID-19 during the period of study from 15 April to 15 May 2021 and from 4 January to 4 February 2022

Exclusion criteria

Exclusion criteria: Patients whose white blood cell count was extremely low and differential leucocyte count could not be done.

Design outcomes

Primary

MeasureTime frame
To study the white blood cell parameters total leucocyte count, percentage of neutrophils, lymphocytes, eosinophils & basophils of the patients admitted during the COVID wave in April May 2021 & during the COVID wave in January February 2022.Timepoint: At baseline—

Secondary

MeasureTime frame
To correlate the white blood cell parameters of patients diagnosed with COVID-19 with the severity of COVID-19 infectionTimepoint: At baseline—

Countries

India

Contacts

Public ContactRashmi Jain Gupta

Lok Nayak Hospital

drrashmijaingupta@gmail.com9873617571

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026